Clinical Trial Update: Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Brigham and Women's Hospital is evaluating the effects of mineralocorticoid receptor modulation on coronary microvascular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hypertension, Left Ventricular Hypertrophy | Phase 4 | Status: RECRUITING